Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

207.05 +2.30 (+1.12%)

Streaming Delayed Price Updated: 11:52 AM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

Johnson & Johnson (NYSE:JNJ) Stands Out as a Top Dividend Stock with Strong Fundamentals ↗

August 26, 2025

Discover Johnson & Johnson (JNJ), a top dividend stock with a strong 2.91% yield, consistent growth, and solid financial health for reliable income.

Via Chartmill

U.S. Leading Economic Index Dips: A Harbinger of Economic Slowdown or a False Alarm?

August 26, 2025

The U.S. Leading Economic Index (LEI) has experienced a consistent decline in recent months, sparking concerns about the nation's economic trajectory for the second half of 2025. While the current...

Via MarketMinute

Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts ↗

August 25, 2025

Powell’s dovish Jackson Hole remarks signal that the Fed could cut rates as early as September, with markets now pricing an 80% chance of a 25 bps cut.

Via MarketBeat

Topics ETFs Economy

This Pharma Giant Is Set To Invest $2B To Expand Manufacturing In North Carolina, And It Just Received A Price Target Hike From Citi: Do You Own It? ↗

August 21, 2025

Via Stocktwits

Bridgewater, Once Led By Ray Dalio, Exits Alibaba, JD, PDD And Baidu, Dumping All US-listed Chinese Stocks Amid Geopolitical Risks ↗

August 25, 2025

Bridgewater's Q2 filing shows a full exit from Chinese stocks like Alibaba, as new management bets big on NVIDIA & JNJ. See all the shifts.

Via Benzinga

3 Dividend Growth Leaders to Buy Now ↗

August 25, 2025

Via MarketBeat

Topics ETFs Economy World Trade

JNJ Stock Surge Signals Confidence in New Growth Path ↗

August 25, 2025

Johnson & Johnson's strategic shift to a focused pharma and medtech model is fueling growth through a powerful drug pipeline and key acquisitions.

Via MarketBeat

Topics Lawsuit

Got $500? 3 Dividend Stocks to Buy and Hold Forever ↗

August 25, 2025

If you're looking for income stocks, this trio of healthcare stocks is a great place to start with $500 (or $5,000).

Via The Motley Fool

The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do. ↗

August 24, 2025

Growth stocks are dominating the S&P 500, pushing the index's dividend yield to a 25-year low.

Via The Motley Fool

Topics ETFs Stocks

2 Dividend Stocks Worth Doubling Down on Right Now ↗

August 24, 2025

These healthcare giants can survive the toughest challenges.

Via The Motley Fool

Topics World Trade

The "Ten Titans" Stocks Now Make Up 38% of the S&P 500. Here's What It Means for Your Investment Portfolio ↗

August 24, 2025

Massive growth stocks are driving the performance of the S&P 500, for better or for worse.

Via The Motley Fool

Topics Economy Stocks

Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks? ↗

August 23, 2025

Investors looking to double down on mega cap stocks like the "Ten Titans" may want to take a closer look at this low-cost ETF.

Via The Motley Fool

Topics ETFs Stocks

Navigating the Peaks and Valleys: A Deep Dive into US Equity Market Valuations

August 22, 2025

The US equity market in mid-2025 presents a complex and often contradictory landscape for investors. While the S&P 500 has flirted with all-time highs, fueled by optimistic economic data and the...

Via MarketMinute

Topics Artificial Intelligence Economy Energy

U.S. Economy Navigates Divergent Signals: Downward Revisions for 2025 Clash with Stronger Q3 Outlook

August 22, 2025

The U.S. economy finds itself at a crossroads, grappling with a complex interplay of growth projections. Recent downward revisions for 2025, coupled with a notable contraction in the first quarter of...

Via MarketMinute

Topics Artificial Intelligence Economy World Trade

J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs ↗

August 22, 2025

Johnson & Johnson (NYSE: JNJ) is set to invest $2 billion in its North Carolina facilities, expanding its U.S. manufacturing operations. This move comes in response to potential drug import tariffs...

Via Benzinga

Topics Government World Trade

3 Stable Dividend-Paying Stocks That Are Perfect for Retirees ↗

August 21, 2025

Names you've heard of with track records to love.

Via The Motley Fool

Topics Retirement

9 Analysts Have This To Say About Johnson & Johnson ↗

August 21, 2025

Via Benzinga

How Do Investors Really Feel About Johnson & Johnson? ↗

August 21, 2025

Via Benzinga

Congressional Trading Report: Rep. Thomas Kean Sold Over $31K In Johnson & Johnson Stock ↗

August 21, 2025

Via Benzinga

Sender Buys Into the Turnaround Story at Kenvue ↗

August 21, 2025

Via The Motley Fool

Topics Regulatory Compliance

Market's Muted Ascent: A Cautious Calm Near Record Highs

August 19, 2025

Despite hovering at or near all-time highs, the major U.S. stock indices—the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite—have recently displayed a remarkably subdued daily performance....

Via MarketMinute

Topics Economy Stocks World Trade

The Unsettling U: U.S. Treasury Yield Curve Signals Market Standoff and Economic Crossroads

August 19, 2025

The U.S. Treasury yield curve has contorted into a rare and unsettling U-shape, a configuration seen in only a fraction of the past five decades. This unusual curve, characterized by high short-term...

Via MarketMinute

Topics Bonds Credit Cards Economy

Wall Street Holds Its Breath: Awaiting Powell's Verdict Amidst Pervasive Caution

August 19, 2025

Wall Street is currently gripped by a palpable "wait-and-see" sentiment, as investors adopt an overwhelmingly cautious stance ahead of Federal Reserve Chair Jerome Powell's highly anticipated speech at...

Via MarketMinute

Topics Economy Stocks

Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage ↗

August 18, 2025

Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 18, 2025

Via Benzinga

Economic Barometer: Consumer Spending and Labor Market Trends Under Scrutiny

August 18, 2025

The global financial landscape is currently navigating a period of heightened uncertainty, with key economic indicators signaling a notable deceleration in private consumption and emerging fragilities...

Via MarketMinute

Topics Economy World Trade

Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm ↗

August 17, 2025

These companies have successfully navigated similar obstacles before.

Via The Motley Fool

Topics Intellectual Property

These Are the 3 Smartest Dividend Stocks Today ↗

August 16, 2025

These three dividend stocks offer steady income and a history of delivering through thick and thin.

Via The Motley Fool

Topics Economy

Federal Reserve Rate Cut Hopes Dwindle as Stubborn Inflation Surges Post-PPI

August 14, 2025

Washington D.C. – Hopes for an imminent Federal Reserve interest rate cut have significantly dimmed following the release of hotter-than-expected Producer Price Index (PPI) data on August 14, 2025. The...

Via MarketMinute

Topics Bonds Economy Stocks

Sector Rotation in Full Swing: Cyclical Stocks Gain Favor as Investors Shift from Tech

August 14, 2025

The financial markets are currently experiencing a significant sector rotation, as investors increasingly shift their capital from growth-oriented technology stocks towards more value-driven cyclical...

Via MarketMinute

Topics Economy

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.